Literature DB >> 21753741

Evidence that clozapine directly interacts on the GABAB receptor.

Ying Wu1, Monica Blichowski, Zafiris J Daskalakis, Zhouyou Wu, Chun C Liu, Miguel A Cortez, Orlando Carter Snead.   

Abstract

Neurophysiological studies suggest that clozapine may facilitate γ-aminobutyric acid (GABAergic) neurotransmission. Therefore, we studied the interaction between clozapine and the GABAB receptor (GABABR). We showed that clozapine, and not N-desmethylclozapine, which is a metabolite of clozapine, increased the binding of the GABABR antagonist, [³H]-CGP54626A, at GABABRs. Linear regression analysis showed that the correlation between the dose of clozapine and the increase of [³H]-CGP54626A binding was significant. The curve of specific [³H]-CGP54626A binding in competition with different concentrations of GABA was left shifted in the presence of clozapine. With HEK293 cells overexpressing GABABR, we showed that clozapine had a significant increase of [³H]-CGP54626A binding at GABABR1 subunit, which provided a clue of the potential therapeutic target of clozapine. 2011 Wolters Kluwer Health | Lippincott Williams & Wilkins.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21753741     DOI: 10.1097/WNR.0b013e328349739b

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  13 in total

Review 1.  Inhibition of the cortex using transcranial magnetic stimulation in psychiatric populations: current and future directions.

Authors:  Natasha Radhu; Lakshmi N Ravindran; Andrea J Levinson; Zafiris J Daskalakis
Journal:  J Psychiatry Neurosci       Date:  2012-11       Impact factor: 6.186

Review 2.  Epigenetic dysregulation in schizophrenia: molecular and clinical aspects of histone deacetylase inhibitors.

Authors:  Alkomiet Hasan; Amanda Mitchell; Anja Schneider; Tobias Halene; Schahram Akbarian
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2013-02-05       Impact factor: 5.270

3.  Evidence for inhibitory deficits in the prefrontal cortex in schizophrenia.

Authors:  Natasha Radhu; Luis Garcia Dominguez; Faranak Farzan; Margaret A Richter; Mawahib O Semeralul; Robert Chen; Paul B Fitzgerald; Zafiris J Daskalakis
Journal:  Brain       Date:  2014-12-17       Impact factor: 13.501

4.  Different pharmacology of N-desmethylclozapine at human and rat M2 and M 4 mAChRs in neocortex.

Authors:  S Gigout; S Wierschke; C Dehnicke; R A Deisz
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2015-01-16       Impact factor: 3.000

Review 5.  Dopaminergic dysfunction and excitatory/inhibitory imbalance in treatment-resistant schizophrenia and novel neuromodulatory treatment.

Authors:  Masataka Wada; Yoshihiro Noda; Yusuke Iwata; Sakiko Tsugawa; Kazunari Yoshida; Hideaki Tani; Yoji Hirano; Shinsuke Koike; Daiki Sasabayashi; Haruyuki Katayama; Eric Plitman; Kazutaka Ohi; Fumihiko Ueno; Fernando Caravaggio; Teruki Koizumi; Philip Gerretsen; Takefumi Suzuki; Hiroyuki Uchida; Daniel J Müller; Masaru Mimura; Gary Remington; Anthony A Grace; Ariel Graff-Guerrero; Shinichiro Nakajima
Journal:  Mol Psychiatry       Date:  2022-04-20       Impact factor: 15.992

Review 6.  Cortical inhibition, excitation, and connectivity in schizophrenia: a review of insights from transcranial magnetic stimulation.

Authors:  Nigel C Rogasch; Zafiris J Daskalakis; Paul B Fitzgerald
Journal:  Schizophr Bull       Date:  2013-05-30       Impact factor: 9.306

Review 7.  Antipsychotic Drug-Induced Somnolence: Incidence, Mechanisms, and Management.

Authors:  Fang Fang; Hongwei Sun; Zuowei Wang; Ming Ren; Joseph R Calabrese; Keming Gao
Journal:  CNS Drugs       Date:  2016-09       Impact factor: 5.749

Review 8.  Opposite regulation of conditioned place preference and intravenous drug self-administration in rodent models: Motivational and non-motivational examples.

Authors:  Thomas A Green; Michael T Bardo
Journal:  Neurosci Biobehav Rev       Date:  2020-06-12       Impact factor: 8.989

9.  Activation of GABA(B) receptors inhibits protein kinase B/glycogen synthase kinase 3 signaling.

Authors:  Frances Fangjia Lu; Ping Su; Fang Liu; Zafiris J Daskalakis
Journal:  Mol Brain       Date:  2012-11-28       Impact factor: 4.041

Review 10.  Binding of clozapine to the GABAB receptor: clinical and structural insights.

Authors:  Pramod C Nair; Ross A McKinnon; John O Miners; Tarun Bastiampillai
Journal:  Mol Psychiatry       Date:  2020-03-13       Impact factor: 15.992

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.